Literature DB >> 32500577

Systematic Review of the Clinical Outcomes of Iron Reduction in Hereditary Hemochromatosis.

Anil Prabhu1, Tamsin Cargill1, Nia Roberts2, John D Ryan1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32500577     DOI： 10.1002/hep.31405

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

1.  Effect of acute iron infusion on insulin secretion: A randomized, double-blind, placebo-controlled trial.

Authors:  Evrim Jaccard; Kévin Seyssel; Alexandre Gouveia; Catherine Vergely; Laila Baratali; Cédric Gubelmann; Marc Froissart; Bernard Favrat; Pedro Marques-Vidal; Luc Tappy; Gérard Waeber
Journal:  EClinicalMedicine       Date:  2022-05-06

2.  What Makes Cirrhosis Irreversible?-Consideration on Structural Changes.

Authors:  Katalin Dezső; Sándor Paku; László Kóbori; Snorri S Thorgeirsson; Péter Nagy
Journal:  Front Med (Lausanne)       Date:  2022-04-27

Review 3.  Revisiting hemochromatosis: genetic vs. phenotypic manifestations.

Authors:  Gregory J Anderson; Edouard Bardou-Jacquet
Journal:  Ann Transl Med       Date:  2021-04

4.  Haemochromatosis in a kidney transplant recipient: a case report.

Authors:  Izabela Zakrocka; Iwona Baranowicz-Gąszczyk; Wojciech Załuska
Journal:  BMC Nephrol       Date:  2021-05-29       Impact factor: 2.388

5.  A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis.

Authors:  Eva Rombout-Sestrienkova; Bjorn Winkens; Marian van Kraaij; Cees Th B M van Deursen; Mirian C H Janssen; Alexander M J Rennings; Dorothea Evers; Jean-Louis Kerkhoffs; Ad Masclee; Ger H Koek
Journal:  J Clin Apher       Date:  2020-12-24       Impact factor: 2.821
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.